Aurobindo Pharma secures FTC nod for Lannett acquisition

Aurobindo Pharma secures FTC nod for Lannett acquisition. The approval clears a key regulatory hurdle for the acquisition of Lannett’s business in the US. This paves the way for Aurobindo to expand its presence in the competitive US generics market. The deal strengthens its product portfolio and manufacturing footprint.
📊 STOCKS: AUROPHARMA | 🏢 SECTOR: Pharma | #HIGHIMPACT #Acquisition